<![CDATA[Zealand Pharma — Maj 2025]]>Er bunden nået for fedmeaktier? Det spørgsmål møder Helge Larsen meget disse dage. Og det er naturligt nok om den sektor, som har fået nogle ordentlige klø, men hvor det den seneste uges tid har set pænt ud. Han kigger på Zealand Pharma, Novo Nordisk, Eli Lilly og Gubra og ser frem mod deres regnskaber, som er lige om hjørnet. Kort video: https://proinvestor.com/boards/126139

]]>https://dev.proinvestor.com/forum/topic/400843/zealand-pharma-maj-2025RSS for NodeSat, 06 Jun 2026 06:08:27 GMTThu, 01 May 2025 11:27:46 GMT60<![CDATA[Reply to Zealand Pharma — Maj 2025 on Thu, 29 May 2025 10:38:41 GMT]]>Maj Status: NVIDIA, toldsatser, Novo, Zealand Pharma, Gubra, Genmab, Embla Kort video: https://proinvestor.com/boards/126575

]]>https://dev.proinvestor.com/forum/post/8036672https://dev.proinvestor.com/forum/post/8036672Thu, 29 May 2025 10:38:41 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 28 May 2025 04:28:23 GMT]]>Aktier/tendens: Novo, DSV og Zealand kan rammes af ny vægtning i ventet flad åbning https://proinvestor.com/investornyt/1321376/aktier-tendens-novo-dsv-og-zealand-kan-rammes-af-ny-vaegtning-i-ventet-flad-abning

]]>https://dev.proinvestor.com/forum/post/8036673https://dev.proinvestor.com/forum/post/8036673Wed, 28 May 2025 04:28:23 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 28 May 2025 03:23:56 GMT]]>Godmorgen 🙂 så er det den mest shortede aktie i DK næsten 10% vildt

]]>https://dev.proinvestor.com/forum/post/8036668https://dev.proinvestor.com/forum/post/8036668Wed, 28 May 2025 03:23:56 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 28 May 2025 03:21:00 GMT]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1321372/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/post/8036671https://dev.proinvestor.com/forum/post/8036671Wed, 28 May 2025 03:21:00 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 10:44:31 GMT]]>Investor om Zealand: “Alt under kurs 800 er et godt opkøbs­ni­veau”

]]>https://dev.proinvestor.com/forum/post/8036664https://dev.proinvestor.com/forum/post/8036664Mon, 26 May 2025 10:44:31 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 10:44:20 GMT]]>
Link Preview Image
Investor om Zealand: “Alt under kurs 800 er et godt opkøbsniveau”

Investor om Zealand: “Alt under kurs 800 er et godt opkøbsniveau”Zealand Pharma sendes højt op i aktiehandlen mandag efter en positiv analyse fra Danske Bank. Banken har indledt sin dækning af det dan

favicon

borsen.dk (borsen.dk)

]]>https://dev.proinvestor.com/forum/post/8036670https://dev.proinvestor.com/forum/post/8036670Mon, 26 May 2025 10:44:20 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 06:46:23 GMT]]>Danske Bank ser kæmpe potentiale i Zealand Pharma-aktien og siger "køb" https://proinvestor.com/investornyt/1321266/danske-bank-ser-kaempe-potentiale-i-zealand-pharma-aktien-og-siger-kob

]]>https://dev.proinvestor.com/forum/post/8036666https://dev.proinvestor.com/forum/post/8036666Mon, 26 May 2025 06:46:23 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 06:19:13 GMT]]>tak

]]>https://dev.proinvestor.com/forum/post/8036669https://dev.proinvestor.com/forum/post/8036669Mon, 26 May 2025 06:19:13 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 05:45:05 GMT]]>Danske Bank: The Roche partnership, coupled with the share declining more than
50% from its peak in June 2024, causes us to find material upside potential in the
current share valuation and our 12M target price of DKK800. We identify upside
potential in our valuation to a share price of DKK1,350.

]]>https://dev.proinvestor.com/forum/post/8036663https://dev.proinvestor.com/forum/post/8036663Mon, 26 May 2025 05:45:05 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 05:16:03 GMT]]>Danske Bank: "We reinitiate coverage of Zealand Pharma with a 12M target price of DKK800 and a Buy recommendation. We base this on the value of Zealand’s obesity portfolio, which we find very promising, coupled with strong partnerships that increase the likelihood of a meaningful market presence."

]]>https://dev.proinvestor.com/forum/post/8036667https://dev.proinvestor.com/forum/post/8036667Mon, 26 May 2025 05:16:03 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 26 May 2025 05:10:20 GMT]]>****ZEALAND PHARMA/DANSKE BANK: GENOPTAGES MED "KØB"

]]>https://dev.proinvestor.com/forum/post/8036665https://dev.proinvestor.com/forum/post/8036665Mon, 26 May 2025 05:10:20 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Fri, 23 May 2025 03:09:41 GMT]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1321060/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/post/8036659https://dev.proinvestor.com/forum/post/8036659Fri, 23 May 2025 03:09:41 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 21 May 2025 16:17:18 GMT]]>Utpal Singh interview

]]>https://dev.proinvestor.com/forum/post/8036662https://dev.proinvestor.com/forum/post/8036662Wed, 21 May 2025 16:17:18 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 21 May 2025 16:16:55 GMT]]>
Link Preview Image
Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Utpal Singh joined the peptide-focused biotech Zealand Pharma last month after it notched a massive obesity deal with Roche.

favicon

Yahoo Finance (finance.yahoo.com)

]]>https://dev.proinvestor.com/forum/post/8036658https://dev.proinvestor.com/forum/post/8036658Wed, 21 May 2025 16:16:55 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Wed, 21 May 2025 02:59:04 GMT]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1319883/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/post/8036656https://dev.proinvestor.com/forum/post/8036656Wed, 21 May 2025 02:59:04 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Tue, 20 May 2025 14:43:01 GMT]]>Transcript fra Proinvestors Q&A med CEO Adam Steensberg fra Zealand Pharma tirsdag d. 20. maj 2025
Moderator: Redaktør Helge Larsen https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Zealand Pharma 2025-05-20.pdf

]]>https://dev.proinvestor.com/forum/post/8036657https://dev.proinvestor.com/forum/post/8036657Tue, 20 May 2025 14:43:01 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Tue, 20 May 2025 13:09:48 GMT]]>Samme her. Stort tak. Det er højt værdsat og meget informativt. Jeg bider mærke i en Adam Steensberg, der bobler af entusiasme og tro på fremtiden for Zealand Pharma. Det er virkeligt fedt.

]]>https://dev.proinvestor.com/forum/post/8036661https://dev.proinvestor.com/forum/post/8036661Tue, 20 May 2025 13:09:48 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Tue, 20 May 2025 12:53:48 GMT]]>Ditto tak fra mig. Bare så fedt med uddybningen omkring aftalen med Roche. 🙂

]]>https://dev.proinvestor.com/forum/post/8036660https://dev.proinvestor.com/forum/post/8036660Tue, 20 May 2025 12:53:48 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Tue, 20 May 2025 12:08:53 GMT]]>Det var så lidt Helge. En stor tak til Adam og dig for en forrygende Q&A.

]]>https://dev.proinvestor.com/forum/post/8036652https://dev.proinvestor.com/forum/post/8036652Tue, 20 May 2025 12:08:53 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Tue, 20 May 2025 12:06:18 GMT]]>Q&A er afsluttet. Tusinde tak til alle for de skarpe spørgsmål. 🙂

]]>https://dev.proinvestor.com/forum/post/8036655https://dev.proinvestor.com/forum/post/8036655Tue, 20 May 2025 12:06:18 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 19 May 2025 11:58:41 GMT]]>Zealand Pharma udpeger Steven Johnson som chef for udvikling https://proinvestor.com/investornyt/1318984/zealand-pharma-udpeger-steven-johnson-som-chef-for-udvikling

]]>https://dev.proinvestor.com/forum/post/8036650https://dev.proinvestor.com/forum/post/8036650Mon, 19 May 2025 11:58:41 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Mon, 19 May 2025 07:47:25 GMT]]>****ZEALAND PHARMA/DEUTSCHE BANK: KURSMÅL SÆNKES TIL 485 KR. FRA 750 KR.

]]>https://dev.proinvestor.com/forum/post/8036648https://dev.proinvestor.com/forum/post/8036648Mon, 19 May 2025 07:47:25 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Thu, 15 May 2025 11:17:33 GMT]]>Pharma-aktier er typisk dem, investorer regner for en sikker havn i urolige tider. Men ikke engang dén sektor er fredet længere, hvor Trump kommer med udmeldinger om told og store prissænkninger på medicin i USA. Hvad kan vi som investorer se frem mod? Hvornår slutter dette mareridt? Det giver Helge Larsen sit bud på. Herudover omtales Lundbecks flotte regnskab og Genmabs udsigt til evt. lidt mindre royalty på Darzalex i 2029. https://proinvestor.com/boards/126377

]]>https://dev.proinvestor.com/forum/post/8036654https://dev.proinvestor.com/forum/post/8036654Thu, 15 May 2025 11:17:33 GMT<![CDATA[Reply to Zealand Pharma — Maj 2025 on Thu, 15 May 2025 03:01:59 GMT]]>OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1317380/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked

]]>https://dev.proinvestor.com/forum/post/8036649https://dev.proinvestor.com/forum/post/8036649Thu, 15 May 2025 03:01:59 GMT